Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy

Journal of Immunology

Volumn 186, Issue 11, 2011, Pages 6173-6181

  Pallikkuth, Suresh ^a   Kanthikeel, Sudheesh Pilakka ^a   Silva, Sandra Y ^a   Fischl, Margaret ^a   Pahwa, Rajendra ^a   Pahwa, Savita ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR;

2009 H1N1 INFLUENZA; ADULT; AGED; ANTIBODY TITER; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; EPIDEMIC; EX VIVO STUDY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPHENOTYPING; INFLUENZA VACCINATION; MALE; MEMORY CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UPREGULATION; VIRUS LOAD;

ADULT; AGED; ANTI-HIV AGENTS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERLEUKINS; MALE; MIDDLE AGED; PLASMA CELLS; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-21; TIME FACTORS; UP-REGULATION; YOUNG ADULT;

EID: 79958074866     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100264     Document Type: Article

References (71)

1. National Center for Immunization and Respiratory Diseases, CDCCenters for Disease Control and Prevention (CDC). 2009. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm. Rep. 58(RR-10): 1-8.
2. Adalja, A. A., and D. A. Henderson. 2010. Original antigenic sin and pandemic (H1N1) 2009. Emerg. Infect. Dis. 16: 1028-1029.
3. Greenbaum, J. A., M. F. Kotturi, Y. Kim, C. Oseroff, K. Vaughan, N. Salimi, R. Vita, J. Ponomarenko, R. H. Scheuermann, A. Sette, and B. Peters. 2009. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc. Natl. Acad. Sci. USA 106: 20365-20370.
4. Hancock, K., V. Veguilla, X. Lu, W. Zhong, E. N. Butler, H. Sun, F. Liu, L. Dong, J. R. DeVos, P. M. Gargiullo, et al. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361: 1945-1952.
5. Reichert, T., G. Chowell, H. Nishiura, R. A. Christensen, and J. A. McCullers. 2010. Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infect. Dis. 10: 5.
6. Greenberg, M. E., M. H. Lai, G. F. Hartel, C. H. Wichems, C. Gittleson, J. Bennet, G. Dawson, W. Hu, C. Leggio, D. Washington, and R. L. Basser. 2009. Response to a monovalent 2009 influenza A (H1N1) vaccine. N. Engl. J. Med. 361: 2405-2413.
7. Klein, M. B., Y. Lu, L. DelBalso, S. Coté, and G. Boivin. 2007. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clin. Infect. Dis. 45: 234-240.
8. Plotkin, S. A. 2010. Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17: 1055-1065.
9. Talbot, H. K., W. Keitel, T. R. Cate, J. Treanor, J. Campbell, R. C. Brady, I. Graham, C. L. Dekker, D. Ho, P. Winokur, et al. 2008. Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine 26: 4057-4061.
10. Tebas, P., I. Frank, M. Lewis, J. Quinn, L. Zifchak, A. Thomas, T. Kenney, R. Kappes, W. Wagner, K. Maffei, K. Sullivan; Center for AIDS Research and Clinical Trials Unit of the University of Pennsylvania. 2010. Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals. AIDS 24: 2187-2192.
11. Kajaste-Rudnitski, A., L. Galli, S. Nozza, G. Tambussi, A. Di Pietro, G. Pellicciotta, A. Monti, P. Mascagni, M. Moro, and E. Vicenzi. 2011. Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals. AIDS 25: 177-183.
12. Ho, J., S. Moir, W. Wang, J. G. Posada, W. Gu, M. T. Rehman, R. Dewar, C. Kovacs, M. C. Sneller, T. W. Chun, et al. 2011. Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza Avaccine on memory B-cell responses in HIV-infected individuals. AIDS 25: 295-302.
13. Bickel, M., I. Wieters, P. Khaykin, G. Nisius, A. Haberl, C. Stephan, N. Von Hentig, E. Herrmann, H. W. Doerr, H. R. Brodt, and R. Allwinn. 2010. Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients. AIDS 24: F31-F35.
14. Good-Jacobson, K. L., and M. J. Shlomchik. 2010. Plasticity and heterogeneity in the generation of memory B cells and long-lived plasma cells: the influence of germinal center interactions and dynamics. J. Immunol. 185: 3117-3125.
15. MacLennan, I. C., K. M. Toellner, A. F. Cunningham, K. Serre, D. M. Sze, E. Zúñiga, M. C. Cook, and C. G. Vinuesa. 2003. Extrafollicular antibody responses. Immunol. Rev. 194: 8-18.
16. Mackay, F., P. Schneider, P. Rennert, and J. Browning. 2003. BAFF AND APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 21: 231-264.
17. Elgueta, R., V. C. de Vries, and R. J. Noelle. 2010. The immortality of humoral immunity. Immunol. Rev. 236: 139-150.
18. Kurosaki, T., H. Shinohara, and Y. Baba. 2010. B cell signaling and fate decision. Annu. Rev. Immunol. 28: 21-55.
19. Avery, D. T., V. L. Bryant, C. S. Ma, R. de Waal Malefyt, and S. G. Tangye. 2008. IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J. Immunol. 181: 1767-1779.
20. Avery, D. T., E. K. Deenick, C. S. Ma, S. Suryani, N. Simpson, G. Y. Chew, T. D. Chan, U. Palendira, J. Bustamante, S. Boisson-Dupuis, et al. 2010. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J. Exp. Med. 207: 155-171.
21. Ettinger, R., G. P. Sims, A. M. Fairhurst, R. Robbins, Y. S. da Silva, R. Spolski, W. J. Leonard, and P. E. Lipsky. 2005. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175: 7867-7879.
22. Ozaki, K., R. Spolski, R. Ettinger, H. P. Kim, G. Wang, C. F. Qi, P. Hwu, D. J. Shaffer, S. Akilesh, D. C. Roopenian, et al. 2004. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173: 5361-5371. (Pubitemid 39392119)
23. Pène, J., J. F. Gauchat, S. Lécart, E. Drouet, P. Guglielmi, V. Boulay, A. Delwail, D. Foster, J. C. Lecron, and H. Yssel. 2004. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J. Immunol. 172: 5154-5157. (Pubitemid 38542010)
24. Morita, R., N. Schmitt, S. E. Bentebibel, R. Ranganathan, L. Bourdery, G. Zurawski, E. Foucat, M. Dullaers, S. Oh, N. Sabzghabaei, et al. 2011. Human blood CXCR5(+) CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34: 108-121.
25. Rankin, A. L., H. MacLeod, S. Keegan, T. Andreyeva, L. Lowe, L. Bloom, M. Collins, C. Nickerson-Nutter, D. Young, and H. Guay. 2011. IL-21 receptor is critical for the development of memory B cell responses. J. Immunol. 186: 667-674.
26. Moir, S., and A. S. Fauci. 2009. B cells in HIV infection and disease. Nat. Rev. Immunol. 9: 235-245.
27. Moir, S., J. Ho, A. Malaspina, W. Wang, A. C. DiPoto, M. A. O'Shea, G. Roby, S. Kottilil, J. Arthos, M. A. Proschan, et al. 2008. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J. Exp. Med. 205: 1797-1805.
28. Moir, S., A. Malaspina, K. M. Ogwaro, E. T. Donoghue, C. W. Hallahan, L. A. Ehler, S. Liu, J. Adelsberger, R. Lapointe, P. Hwu, et al. 2001. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc. Natl. Acad. Sci. USA 98: 10362-10367.
29. Kroon, F. P., G. F. Rimmelzwaan, M. T. Roos, A. D. Osterhaus, D. Hamann, F. Miedema, and J. T. van Dissel. 1998. Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy. AIDS 12: F217-F223. (Pubitemid 28526400)
30. Malaspina, A., S. Moir, S. M. Orsega, J. Vasquez, N. J. Miller, E. T. Donoghue, S. Kottilil, M. Gezmu, D. Follmann, G. M. Vodeiko, et al. 2005. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J. Infect. Dis. 191: 1442-1450.
31. Titanji, K., A. De Milito, A. Cagigi, R. Thorstensson, S. Grützmeier, A. Atlas, B. Hejdeman, F. P. Kroon, L. Lopalco, A. Nilsson, and F. Chiodi. 2006. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 108: 1580-1587. (Pubitemid 44316125)
32. Chevalier, M. F., B. Jülg, A. Pyo, M. Flanders, S. Ranasinghe, D. Z. Soghoian, D. S. Kwon, J. Rychert, J. Lian, M. I. Muller, et al. 2011. HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. J. Virol. 85: 733-741.
33. Williams, L. D., A. Bansal, S. Sabbaj, S. L. Heath, W. Song, J. Tang, A. J. Zajac, and P. A. Goepfert. 2011. Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers. J. Virol. 85: 2316-2324.
34. Yue, F. Y., C. Lo, A. Sakhdari, E. Y. Lee, C. M. Kovacs, E. Benko, J. Liu, H. Song, R. B. Jones, P. Sheth, et al. 2010. HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control. J. Immunol. 185: 498-506.
35. Böyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. Suppl. 97: 77-89.
36. Maecker, H. T., and J. Trotter. 2006. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 69: 1037-1042. (Pubitemid 44521985)
37. Perfetto, S. P., D. Ambrozak, R. Nguyen, P. Chattopadhyay, and M. Roederer. 2006. Quality assurance for polychromatic flow cytometry. Nat. Protoc. 1: 1522-1530.
38. Moir, S., A. Malaspina, J. Ho, W. Wang, A. C. Dipoto, M. A. O'Shea, G. Roby, J. M. Mican, S. Kottilil, T. W. Chun, et al. 2008. Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. J. Infect. Dis. 197: 572-579.
39. Good, K. L., V. L. Bryant, and S. G. Tangye. 2006. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J. Immunol. 177: 5236-5247.
40. Kyu, S. Y., J. Kobie, H. Yang, M. S. Zand, D. J. Topham, S. A. Quataert, I. Sanz, and F. E. Lee. 2009. Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells. J. Immunol. Methods 340: 42-47.
41. Buseyne, F., A. Catteau, D. Scott-Algara, B. Corre, F. Porrot, C. Rouzioux, S. Blanche, and Y. Rivière. 2005. A vaccinia-based elispot assay for detection of CD8+ T cells from HIV-1 infected children. J. Immunol. Methods 298: 105-118. (Pubitemid 40545097)
42. Crotty, S., R. D. Aubert, J. Glidewell, and R. Ahmed. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286: 111-122.
43. Wrammert, J., K. Smith, J. Miller, W. A. Langley, K. Kokko, C. Larsen, N. Y. Zheng, I. Mays, L. Garman, C. Helms, et al. 2008. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453: 667-671. (Pubitemid 351769295)
44. Iannello, A., M. R. Boulassel, S. Samarani, O. Debbeche, C. Tremblay, E. Toma, J. P. Routy, and A. Ahmad. 2010. Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study. J. Immunol. 184: 114-126.
45. Malaspina, A., S. Moir, J. Ho, W. Wang, M. L. Howell, M. A. O'Shea, G. A. Roby, C. A. Rehm, J. M. Mican, T. W. Chun, and A. S. Fauci. 2006. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc. Natl. Acad. Sci. USA 103: 2262-2267.
46. Galli, G., K. Hancock, K. Hoschler, J. DeVos, M. Praus, M. Bardelli, C. Malzone, F. Castellino, C. Gentile, T. McNally, et al. 2009. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. Proc. Natl. Acad. Sci. USA 106: 7962-7967.
47. Sasaki, S., M. C. Jaimes, T. H. Holmes, C. L. Dekker, K. Mahmood, G. W. Kemble, A. M. Arvin, and H. B. Greenberg. 2007. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J. Virol. 81: 215-228.
48. Marie-Cardine, A., F. Divay, I. Dutot, A. Green, A. Perdrix, O. Boyer, N. Contentin, H. Tilly, F. Tron, J. P. Vannier, and S. Jacquot. 2008. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin. Immunol. 127: 14-25.
49. Brokstad, K. A., R. J. Cox, J. Olofsson, R. Jonsson, and L. R. Haaheim. 1995. Parenteral influenza vaccination induces a rapid systemic and local immune response. J. Infect. Dis. 171: 198-203.
50. Brokstad, K. A., R. J. Cox, J. S. Oxford, and L. R. Haaheim. 1995. IgA, IgA subclasses, and secretory component levels in oral fluid collected from subjects after parental influenza vaccination. J. Infect. Dis. 171: 1072-1074.
51. el-Madhun, A. S., R. J. Cox, A. Søreide, J. Olofsson, and L. R. Haaheim. 1998. Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination. J. Infect. Dis. 178: 933-939.
52. Bryant, V. L., C. S. Ma, D. T. Avery, Y. Li, K. L. Good, L. M. Corcoran, R. de Waal Malefyt, and S. G. Tangye. 2007. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol. 179: 8180-8190.
53. White, L., S. Krishnan, N. Strbo, H. Liu, M. A. Kolber, M. G. Lichtenheld, R. N. Pahwa, and S. Pahwa. 2007. Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV). Blood 109: 3873-3880. (Pubitemid 46641739)
54. Jin, H., R. Carrio, A. Yu, and T. R. Malek. 2004. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J. Immunol. 173: 657-665.
55. Caprioli, F., M. Sarra, R. Caruso, C. Stolfi, D. Fina, G. Sica, T. T. MacDonald, F. Pallone, and G. Monteleone. 2008. Autocrine regulation of IL-21 production in human T lymphocytes. J. Immunol. 180: 1800-1807.
56. Linterman, M. A., L. Beaton, D. Yu, R. R. Ramiscal, M. Srivastava, J. J. Hogan, N. K. Verma, M. J. Smyth, R. J. Rigby, and C. G. Vinuesa. 2010. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 207: 353-363.
57. Zotos, D., J. M. Coquet, Y. Zhang, A. Light, K. D'Costa, A. Kallies, L. M. Corcoran, D. I. Godfrey, K. M. Toellner, M. J. Smyth, et al. 2010. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J. Exp. Med. 207: 365-378.
58. Diehl, S. A., H. Schmidlin, M. Nagasawa, S. D. van Haren, M. J. Kwakkenbos, E. Yasuda, T. Beaumont, F. A. Scheeren, and H. Spits. 2008. STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J. Immunol. 180: 4805-4815.
59. Kurosaki, T., Y. Aiba, K. Kometani, S. Moriyama, and Y. Takahashi. 2010. Unique properties of memory B cells of different isotypes. Immunol. Rev. 237: 104-116.
60. Avery, D. T., S. L. Kalled, J. I. Ellyard, C. Ambrose, S. A. Bixler, M. Thien, R. Brink, F. Mackay, P. D. Hodgkin, and S. G. Tangye. 2003. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112: 286-297.
61. MacLennan, I., and C. Vinuesa. 2002. Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity 17: 235-238. (Pubitemid 35279545)
62. Benson, M. J., L. D. Erickson, M. W. Gleeson, and R. J. Noelle. 2007. Affinity of antigen encounter and other early B-cell signals determine B-cell fate. Curr. Opin. Immunol. 19: 275-280.
63. Frasca, D., A. Diaz, M. Romero, A. M. Landin, M. Phillips, S. C. Lechner, J. G. Ryan, and B. B. Blomberg. 2010. Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 28: 8077-8084.
64. Pahwa, S. G., R. N. Pahwa, and R. A. Good. 1981. Decreased in vitro humoral immune responses in aged humans. J. Clin. Invest. 67: 1094-1102.
65. Appay, V., J. R. Almeida, D. Sauce, B. Autran, and L. Papagno. 2007. Accelerated immune senescence and HIV-1 infection. Exp. Gerontol. 42: 432-437.
66. Cao, W., B. D. Jamieson, L. E. Hultin, P. M. Hultin, R. B. Effros, and R. Detels. 2009. Premature aging of T cells is associated with faster HIV-1 disease progression. J. Acquir. Immune Defic. Syndr. 50: 137-147.
67. Effros, R. B., C. V. Fletcher, K. Gebo, J. B. Halter, W. R. Hazzard, F. M. Horne, R. E. Huebner, E. N. Janoff, A. C. Justice, D. Kuritzkes, et al. 2008. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin. Infect. Dis. 47: 542-553.
68. Katsenelson, N., S. Kanswal, M. Puig, H. Mostowski, D. Verthelyi, and M. Akkoyunlu. 2007. Synthetic CpG oligodeoxynucleotides augment BAFF-and APRIL-mediated immunoglobulin secretion. Eur. J. Immunol. 37: 1785-1795.
69. Mantchev, G. T., C. S. Cortesão, M. Rebrovich, M. Cascalho, and R. J. Bram. 2007. TACI is required for efficient plasma cell differentiation in response to T-independent type 2 antigens. J. Immunol. 179: 2282-2288.
70. Zhang, X., C. S. Park, S. O. Yoon, L. Li, Y. M. Hsu, C. Ambrose, and Y. S. Choi. 2005. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Int. Immunol. 17: 779-788.
71. Ettinger, R., G. P. Sims, R. Robbins, D. Withers, R. T. Fischer, A. C. Grammer, S. Kuchen, and P. E. Lipsky. 2007. IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J. Immunol. 178: 2872-2882.